Cargando…

Anti‐synthetase syndrome associated interstitial lung disease after combination dual immune checkpoint inhibition

Immune checkpoint inhibitors (ICIs) unleash potent anti‐tumour responses but with frequent off‐target immune‐mediated adverse events (irAE). ICIs can induce a spectrum of rheumatologic manifestations including inflammatory arthritis, Sjögren's syndrome, scleroderma and systemic lupus erythemato...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bell, Peter T., Beaton, Thomas, Terrill, Matthew, Gillis, David, Goddard, John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2023
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10009905/ https://www.ncbi.nlm.nih.gov/pubmed/36923607 http://dx.doi.org/10.1002/rcr2.1115

Ejemplares similares

Interstitial Lung Disease in Anti-Synthetase Syndrome
por: Kourkouni, Evangelia, et al.
Publicado: (2019)

Anti-synthetase syndrome presenting with interstitial lung disease
por: Athanassiou, Panagiotis, et al.
Publicado: (2017)

Anti-Synthetase Syndrome-Related Interstitial Lung Disease With Anti-PL-12 Antibodies
por: Elferjani, Belqis, et al.
Publicado: (2021)

Single-Cell Transcriptomics Reveals Peripheral Immune Responses in Anti-Synthetase Syndrome-Associated Interstitial Lung Disease
por: Zhu, Lili, et al.
Publicado: (2022)

Successful baricitinib treatment of refractory anti‐synthetase syndrome associated with interstitial lung disease
por: Sugino, Keishi, et al.
Publicado: (2023)

Clinical characteristics of interstitial lung diseases positive to different anti-synthetase antibodies
por: Jiang, Minna, et al.
Publicado: (2021)

Interstitial lung disease is a major characteristic of anti-KS associated ant-synthetase syndrome
por: Ge, Yongpeng, et al.
Publicado: (2020)

A narrative review of interstitial lung disease in anti-synthetase syndrome: a clinical approach
por: Sawal, Naina, et al.
Publicado: (2021)

Prediction of progressive pulmonary fibrosis in patients with anti-synthetase syndrome-associated interstitial lung disease
por: Fu, Hongyan, et al.
Publicado: (2023)

Clinical features of anti-synthetase syndrome associated interstitial lung disease: a retrospective cohort in China
por: Zhan, Xi, et al.
Publicado: (2021)

Correction to: Prediction of progressive pulmonary fibrosis in patients with anti-synthetase syndrome-associated interstitial lung disease
por: Fu, Hongyan, et al.
Publicado: (2023)

Granulomatous lymphocytic interstitial lung disease: limiting immunosuppressive therapy—a single‐centre experience
por: Beaton, Thomas J., et al.
Publicado: (2020)

Combination of dual mTORC1/2 inhibition and immune-checkpoint blockade potentiates anti-tumour immunity
por: Langdon, Sophie, et al.
Publicado: (2018)

Acute interstitial pneumonia as first presentation of anti-synthetase syndrome: an atypical case
por: Jan, Kalimullah, et al.
Publicado: (2018)

Acute Onset Anti-Synthetase Syndrome With Pericardial Effusion and Non-Specific Interstitial Pneumonia
por: Shah, Aditya, et al.
Publicado: (2016)

Clinical Characteristics of Anti-Synthetase Syndrome and Variables Associated with Interstitial Lung Disease and Mortality: A Retrospective Cohort Study
por: Sodsri, Tulaton, et al.
Publicado: (2023)

Different Multivariable Risk Factors for Rapid Progressive Interstitial Lung Disease in Anti-MDA5 Positive Dermatomyositis and Anti-Synthetase Syndrome
por: Zuo, Yu, et al.
Publicado: (2022)

Fulminant Respiratory Failure Caused by Anti-asparaginyl tRNA Synthetase (Anti-KS) Antibody Syndrome-related Interstitial Lung Disease
por: Oda, Naohiro, et al.
Publicado: (2022)

Anti-synthetase syndrome-associated interstitial lung disease possibly caused by atezolizumab in a patient with lung adenocarcinoma: a case report
por: Miyamoto, Ippei, et al.
Publicado: (2023)

Association of Preexisting Interstitial Lung Abnormalities With Immune Checkpoint Inhibitor–Induced Interstitial Lung Disease Among Patients With Nonlung Cancers
por: Shimoji, Kiyofumi, et al.
Publicado: (2020)

Aminoacyl-tRNA Synthetases: On Anti-Synthetase Syndrome and Beyond
por: Galindo-Feria, Angeles S., et al.
Publicado: (2022)

Pemetrexed combined with dual immune checkpoint blockade enhances cytotoxic T lymphocytes against lung cancer
por: Chen, Mei‐Chih, et al.
Publicado: (2023)

Clinical significance of interstitial lung abnormalities and immune checkpoint inhibitor‐induced interstitial lung disease in patients with non‐small cell lung cancer
por: Murata, Daiki, et al.
Publicado: (2022)

Long-term clinical course of anti-glycyl tRNA synthetase (anti-EJ) antibody-related interstitial lung disease pathologically proven by surgical lung biopsy
por: Sasano, Hajime, et al.
Publicado: (2016)

Acute interstitial nephritis related to immune checkpoint inhibitors
por: Belliere, Julie, et al.
Publicado: (2016)

Enhancing therapeutic anti-cancer responses by combining immune checkpoint and tyrosine kinase inhibition
por: Daly, Roger J., et al.
Publicado: (2022)

Immune checkpoint inhibitor-related pneumonitis with atypical radiologic features in a patient with anti-aminoacyl-tRNA synthetase antibody
por: Ichihara, Seiya, et al.
Publicado: (2022)

Severe acute interstitial nephritis after combination immune-checkpoint inhibitor therapy for metastatic melanoma
por: Murakami, Naoka, et al.
Publicado: (2016)

Severe acute interstitial nephritis after combination immune-checkpoint inhibitor therapy for metastatic melanoma
por: Murakami, Naoka, et al.
Publicado: (2016)

Combining Immune Checkpoint Inhibitors with Anti-Angiogenic Agents
por: Ciciola, Paola, et al.
Publicado: (2020)

Novel case of anti-synthetase syndrome
por: Kapoor, Aniruddh, et al.
Publicado: (2018)

CNS Vasculitis in Anti-Synthetase Syndrome
por: Shipa, Muhammad, et al.
Publicado: (2019)

Prospects for combining immune checkpoint blockade with PARP inhibition
por: Li, Anping, et al.
Publicado: (2019)

Enhanced Activity of NLRP3 Inflammasome in the Lung of Patients with Anti-Synthetase Syndrome
por: Ramos-Martinez, Espiridión, et al.
Publicado: (2022)

Combination of Immune Checkpoint Inhibitors with Chemotherapy in Lung Cancer
por: Liu, Wei, et al.
Publicado: (2020)

Checkpoint kinase 1/2 inhibition potentiates anti-tumoral immune response and sensitizes gliomas to immune checkpoint blockade
por: Dmello, Crismita, et al.
Publicado: (2023)

Tracheal Ulcers Associated with Anti-synthetase Syndrome
por: Yamakawa, Hideaki, et al.
Publicado: (2019)

Anti-synthetase Syndrome: A Diagnostic Dilemma
por: Aslam, Muniba, et al.
Publicado: (2023)

Prognostic Significance of Anti-Aminoacyl-tRNA Synthetase Antibodies in Polymyositis/Dermatomyositis-Associated Interstitial Lung Disease: A Retrospective Case Control Study
por: Hozumi, Hironao, et al.
Publicado: (2015)

Hyperacute Onset of Immune Checkpoint Inhibitor–Related Acute Interstitial Nephritis
por: Tawhari, Ibrahim, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_iateg730evnm1scrbriu80bkp7